Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR ‐153‐3p/SATB1 signaling pathway

ConclusionTriptolide could hinder ESCC progression, which was mainly achieved by regulating the circNOX4/miR-153-3p/SATB1 axis.

Source: Thoracic Cancer - January 25, 2024 Category: Cancer & Oncology Authors: Hanping Liang, Weibi Che, Fengyuan Peng, Huilong Chen, Xihao Xie, Bomeng Wu Tags: ORIGINAL ARTICLE Source Type: research